NCT05348980View on ClinicalTrials.gov

Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
HypotensionAnesthesia
Interventions
DRUG

Phenylephrine Hydrochloride 4 mg

Intramuscular Phenylephrine HCL 04 mg were administered as prophylactic stat dose in Vastus lateralis muscle of thigh 05 minutes before giving spinal anesthesia.

DRUG

Phenylephrine Hydrochloride 8 mg

Intramuscular Phenylephrine HCL 08 mg were administered as prophylactic stat dose in Vastus lateralis muscle of thigh 05 minutes before giving spinal anesthesia.

Trial Locations (1)

25000

Rehman Medical Institute, Peshawar

All Listed Sponsors
lead

Rehman Medical Institute - RMI

OTHER

NCT05348980 - Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension | Biotech Hunter | Biotech Hunter